OncoMatch/Clinical Trials/NCT05965817
Fluorescence-guided Resection Of Colorectal Liver Metastases Using SGM-101 and Indocyanine GREEN
Is NCT05965817 recruiting? Yes, currently enrolling (May 2026). This Phase 2 trial studies SGM-101 op top of ICG for colorectal cancer.
Treatment: SGM-101 op top of ICG — This will be the first trial testing the feasibility of working simultaneously with the two fluorescent dyes ICG and SGM-101 in 10 patients with colorectal metastases.
Check if I qualifyExtracted eligibility criteria
Cancer type
Colorectal Cancer
Disease stage
Metastatic disease required
Structured fields extracted by AI. May contain errors — verify against the official protocol.
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualify